To compare and evaluate the analgesic effect of dexmedetomidine 0.5mcg/kg as an adjuvant to 0.25% ropivacaine vs 0.25% ropivacaine alone in transverses abdominis plane block in infraumblical surgeries with regards to duration of analgesia and post operative analgesic consumption in 24 hours.
Not Applicable
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2019/05/019255
- Lead Sponsor
- Dr Bhabesh Prasad Panda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) American Society of Anesthesiologists (ASA) grades I and II.
2) Male or female aged 18-65 years.
3) Patients undergoing infraumbilical surgeries like hernia repair, mesh hernioplasty, appendicectomy under spinal anesthesia.
Exclusion Criteria
1) Patients with any contraindication to regional anesthesia like-
2) Patientâ??s refusal for TAP block.
3) Patients with local skin infection.
4) ASA-III & ASA-IV
5) Obese patients with BMI >30 kg/m2.
6) Patients with a history of anaphylaxis to local anesthetics and allergy to the study drugs.
7) Pregnant or lactating patients.
8) Patients with a history of pulmonary, cardiac, hematological, endocrinal or neuromuscular disorders.
9) Patients with a history of underlying psychological disorder.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the duration of postoperative analgesic effect between ropivacaine alone and ropivacaine with dexmedetomidine in ultrasound guided transverse abdominis plane block.Timepoint: 12 Months
- Secondary Outcome Measures
Name Time Method To compare quality of analgesia and total postoperative analgesic consumption in 24 hours between ropivacaine alone and ropivacaine with dexmedetomidine in ultrasound guided transverse abdominis plane block.Timepoint: 12 months